Key facts
- Yuwang BioNutrition’s last known valuation is $129.3M (Aug 2025).
- It has raised $19.4M; the latest was IPO in Oct 2025.
- Notable investors include Bayland Health.
- Status: In IPO Registration.
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Yuwang BioNutrition
- ·The full record, as it builds
Funding rounds
No funding rounds for Yuwang BioNutrition are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Yuwang BioNutrition
Producer of food-grade refined fish oil and its products for health maintenance. The company is committed to the industrial-scale production of food-grade fish oil and pharmaceutical-grade fish oil, permitting to meet customers' needs for health supplements.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Dezhou, China
- Founded
- 1989
- Employees
- 354
- Website
- yuwangnutri.com/
- Ownership
- In IPO Registration
Yuwang BioNutrition doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Yuwang BioNutrition shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Yuwang BioNutrition in its N-PORT filings yet. We sweep new filings monthly.